- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02014675
SD01 Registry (SD01 ICD Lead) (SD01 Registry)
January 22, 2024 updated by: Biotronik SE & Co. KG
This registry is designed to gather further evidence, in addition to the SD01 Master Study, for the safety and efficacy of the SD01 ICD lead.
Study Overview
Status
Active, not recruiting
Intervention / Treatment
Study Type
Observational
Enrollment (Estimated)
280
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Berlin, Germany
- DRK Klinikum Berlin-Köpenick
-
Berlin, Germany
- Vivantes Humboldt Klinikum Berlin
-
Hamburg, Germany
- Universitares Herzzentrum Hamburg
-
Leverkusen, Germany
- Klinikum Leverkusen
-
Lübeck, Germany, 23538
- University Clinic of Schleswig-Holstein
-
Merseburg, Germany
- Carl-von-Basedow Klinik
-
Papenburg, Germany
- Marienkrankenhaus Papenburg
-
Ratzeburg, Germany
- DRK Krankenhaus Moelln-Ratzeburg
-
Suhl, Germany
- SRH Zentralklinikum Suhl
-
Würzburg, Germany
- Universitätsklinik Würzburg
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Patients with standard ICD/CRT-D (cardiac resynchronization therapy plus defibrillator) indication
Description
Inclusion Criteria:
- Meet a standard indication for ICD/CRT-D therapy
- First ICD/CRT-D implantation or upgrade from pacemaker
- Signed informed consent form
- Willing to participate for the whole duration of the registry
- Patient accepts Home Monitoring concept and is able to activate and use the Cardiomessenger
- Patient has legal capacity and ability to consent
Exclusion Criteria:
- Meet a standard contraindication for an ICD/CRT-D therapy
- Age <18 years
- Pregnant or breast-feeding women
- Cardiac surgery planned within the next six months
- Enrollment in another cardiac clinical investigation with active treatment arm
- Mechanical tricuspid valve prosthesis or severe tricuspid valve disease
- Dexamethasone acetate intolerance
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
SD01 ICD lead
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
SADE-free rate
Time Frame: 10 years
|
10 years
|
Other Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Pacing threshold of SD01
Time Frame: 3-month follow-up
|
3-month follow-up
|
Sensing amplitude of SD01
Time Frame: 3-month follow-up
|
3-month follow-up
|
Device deficiencies
Time Frame: 10 years
|
10 years
|
Long-term pacing impedance, pacing threshold, sensing amplitude and painless shock impedance of SD01 and other leads, if applicable
Time Frame: 10 years
|
10 years
|
Analysis of arrhythmias and their treatment
Time Frame: until 3-month follow-up
|
until 3-month follow-up
|
ICD/CRT-D system performance
Time Frame: 10 years
|
10 years
|
SD01 implantation information, handling and operation time record
Time Frame: Implantation
|
Implantation
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2014
Primary Completion (Estimated)
December 1, 2024
Study Completion (Estimated)
April 1, 2025
Study Registration Dates
First Submitted
December 4, 2013
First Submitted That Met QC Criteria
December 12, 2013
First Posted (Estimated)
December 18, 2013
Study Record Updates
Last Update Posted (Actual)
January 23, 2024
Last Update Submitted That Met QC Criteria
January 22, 2024
Last Verified
January 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 67 (TA108)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Heart Failure
-
Tufts Medical CenterMetro West Medical CenterCompletedCongestive Heart Failure | Diastolic Heart Failure | Systolic Heart FailureUnited States
-
Abbott Medical DevicesCompletedHeart Failure | Heart Failure, Diastolic | Heart Failure, Systolic | Heart Failure NYHA Class II | Heart Failure NYHA Class III | Heart Failure With Reduced Ejection Fraction | Heart Failure NYHA Class IV | Heart Failure With Normal Ejection Fraction | Heart Failure; With Decompensation | Heart Failure...United States, Canada
-
Manipal UniversityUnknownHeart Failure | Decompensated Heart Failure | Acute Heart Failure | Diastolic Heart Failure | Systolic Heart FailureIndia
-
VA Eastern Colorado Health Care SystemNational Institute on Aging (NIA)CompletedHeart Failure | Heart Failure, Diastolic | Heart Failure, Systolic | Heart Failure With Reduced Ejection Fraction | Heart Failure With Preserved Ejection Fraction | Heart Failure; With Decompensation | Heart Failure,Congestive | Heart Failure AcuteUnited States
-
University Hospital, MontpellierCompletedHeart Failure | Diastolic Heart Failure | Systolic Heart Failure Stage CFrance
-
Wake Forest UniversityCompletedHeart Failure, Congestive | Heart Failure With Preserved Ejection Fraction
-
Lancaster General HospitalLouise von Hess Medical Research InstituteEnrolling by invitationDiastolic Heart FailureUnited States
-
Wake Forest UniversityNational Institute on Aging (NIA)CompletedHeart Failure, Congestive | Diastolic Heart FailureUnited States
-
Giresun UniversityIstanbul University - Cerrahpasa (IUC)RecruitingHeart Failure | Diastolic Heart Failure | Systolic Heart FailureTurkey
-
US Department of Veterans AffairsCompleted
Clinical Trials on SD01 ICD lead
-
Biotronik SE & Co. KGActive, not recruitingHeart Failure | Ventricular Fibrillation | Ventricular TachycardiaGermany, Hungary, France, Czechia, Latvia
-
Biotronik, Inc.CompletedPatients Indicated for an ICDUnited States
-
Biotronik SE & Co. KGCompletedHeart Failure | TachyarrhythmiaDenmark, France, Germany, Spain, Switzerland, Israel, Latvia, Australia, Singapore, Austria
-
AtaCor Medical, Inc.CompletedVentricular Fibrillation | Ventricular Tachycardia | Ventricular ArrhythmiaParaguay
-
Biotronik SE & Co. KGActive, not recruitingHeart Failure | TachyarrhythmiaHungary, Latvia, Israel, Belgium, Germany, Australia, Austria, Slovakia
-
AtaCor Medical, Inc.CompletedVentricular Fibrillation | Ventricular Tachycardia | Ventricular ArrhythmiaParaguay
-
AtaCor Medical, Inc.CompletedVentricular Fibrillation | Ventricular Tachycardia | Ventricular ArrythmiaParaguay
-
Charles BerulMedtronic; Guidant CorporationTerminatedVentricular Fibrillation | Ventricular Tachycardia | Congenital Heart Disease | Cardiomyopathy | Long QT SyndromeUnited States
-
Abbott Medical DevicesCompletedImplantable Defibrillator UserHungary, United States, Poland, Spain, United Kingdom
-
Weill Medical College of Cornell UniversityBiotronik, Inc.CompletedAtrial FibrillationUnited States